RISK ASSESSMENT – ROUNDTABLE DISCUSSION
“KICK OFF TO A MANAGED RISK-FREE JOURNEY”
Webinar:
Tuesday, August 30th, 2022 (1:00 PM EST )

Gary Bierc
CEO Risk Management Systems,
Cross-Industy subject matter expert

Elise Roth
Compliance Consultant
Former Device CCO

Ned Mumtaz
Director Compliance Services
Wyeth and Merck Pharmaceuticals

Heidi Kocher
Life Sciences Partner

Marc Ussini
Director Compliance Services
J&J and Genentech
Join this webinar with Vector Health and Industry professionals on risk assessment, and tracking, assembled from life sciences, financial, and high-tech industries to be part of a powerful discussion on risk assessment covering the most efficient methods and strategies to avoid overanalyzing while protecting your business.
Key Takeaways:
- Strategic Risk Assessment Principles and Business Impact Analysis (BIA) to eradicate potential hazards.
- Efficient techniques to mitigate risk from traditional whiteboard approaches to numerical probabilistic methods such as Monte Carlos Stimulation.
- Thorough understanding of new uncharted areas such as cybercrimes, data theft, and digital financial frauds to traditional challenges around IP protection, corporate espionage and anti-bribery, fraud, and whistleblower challenges.
- How does one weave in causation, consequences, key risk indicators, heat maps, simulation models, benchmarking, CAPAs, and more into a holistic meaningful measure of risk?
- Benefits of risk assessment to regulatory affairs, compliance officers, clinical affairs personnel, and the board. What do they expect from you? How?
Attend a LIVE powerful discussion of industry peers and cross-industry risk experts while availing yourself of the opportunity of participating in the LIVE discussion and Q&A SESSION.